Stock Events

Stock Events

Wuxi Biologics (Cayman) 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26AugExpected
Q4 2025
Next
0.08
0.08
0.08
0.08
Expected EPS
0.07607024792400001
Actual EPS
N/A

Financials

22.51%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.62BRevenue
590.02MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1FW.MU. It's not an investment recommendation.
Apple
12
AAPL
Microsoft
11
MSFT
NVIDIA
10
NVDA
Alphabet
9
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sartorius
SARTF
Mkt Cap14.69B
Sartorius Stedim Biotech is a supplier of equipment and services for biopharmaceutical manufacturing, competing in the bioprocessing space with Wuxi Biologics.
Charles River Laboratories International
CRL
Mkt Cap11.11B
Charles River Laboratories offers a broad range of services to support the pharmaceutical and biotech industries, including biologics testing services.
Thermo Fisher Scientific
TMO
Mkt Cap194.52B
Thermo Fisher Scientific provides bioproduction and bioprocessing products and services, competing with Wuxi Biologics in the supply of critical biomanufacturing technologies.
Danaher
DHR
Mkt Cap140.09B
Danaher, through its subsidiaries like Cytiva, competes in the bioprocessing space by providing technologies and services for biomanufacturing.
Bio-Rad Laboratories
BIO
Mkt Cap7.94B
Bio-Rad Laboratories offers products and services in the field of life science research and clinical diagnostics, competing in the biologics tools and services market.
IQVIA
IQV
Mkt Cap34.55B
IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing in the broader biopharmaceutical services market.
Pfizer
PFE
Mkt Cap138.61B
Pfizer, through its contract manufacturing organization Pfizer CentreOne, competes in the biologics manufacturing and development services sector.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, while primarily a biopharmaceutical company, competes for resources, talent, and market share in the biologics sector, particularly in areas of overlapping therapeutic interest.

About

WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitates international sales contracting, develops and performs advanced testing services, and manages sales and marketing initiatives. Furthermore, it provides clinical and manufacturing support for biologics, manufactures and distributes medical products, serves as a contract development and manufacturing organization (CDMO) for vaccines, and functions as a material supplier. WuXi Biologics maintains significant strategic collaborations with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc. The organization, founded in 2014, is headquartered in Wuxi, China.
Show more...
CEO
ISIN
KYG970081090

Listings

MU
DE
1FW.MU
STU
DE
1FW1.STU
STU
DE
1FW2.STU
MU
DE
1FW1.MU

0 Comments

Share your thoughts

FAQ

What is Wuxi Biologics (Cayman) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Wuxi Biologics (Cayman) stocks are traded under the ticker 1FW.MU.
When is the next Wuxi Biologics (Cayman) earnings date?▼
Wuxi Biologics (Cayman) is going to release the next earnings report on August 26, 2026.
What is Wuxi Biologics (Cayman) revenue for the last year?▼
Wuxi Biologics (Cayman) revenue for the last year amounts to 2.62B EUR.
What is Wuxi Biologics (Cayman) net income for the last year?▼
1FW.MU net income for the last year is 590.02M EUR.
In which sector is Wuxi Biologics (Cayman) located?▼
Wuxi Biologics (Cayman) operates in the Other sector.
When did Wuxi Biologics (Cayman) complete a stock split?▼
Wuxi Biologics (Cayman) has not had any recent stock splits.